academic article

• Biomarkers of Alzheimer's disease in Black and/or African American Alzheimer's Disease Neuroimaging Initiative (ADNI) participants..  Neurobiology of aging.  144-152. 2023
• Non-tremor motor dysfunction in Lewy body dementias is associated with AD biomarkers..  Parkinsonism & related disorders.  33-36. 2022
• Cognitive Profile and Markers of Alzheimer Disease-Type Pathology in Patients With Lewy Body Dementias..  Neurology.  96:e1855-e1864. 2021
• Tau pathology associates with in vivo cortical thinning in Lewy body disorders..  Annals of clinical and translational neurology.  7:2342-2355. 2020
• The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease..  PloS one.  13:-. 2018
• APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease..  Movement disorders : official journal of the Movement Disorder Society.  33:289-297. 2017
• Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects..  Brain : a journal of neurology.  138:2701-15. 2015
• Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers..  NeuroImage. Clinical.  164-73. 2013